In this issue:
Survival of patients with advanced metastatic melanoma: MAP kinase pathway inhibition vs ICI
ICI therapy and irAEs in advanced melanoma
Evaluation of sex-specific incidence of melanoma
Estimated risk of progression of lentigo maligna to lentigo maligna melanoma
Survival in 31 670 Swedish patients with thin melanomas
Factors affecting SN metastasis in T1 cutaneous melanomas and development of a predictive nomogram
Association of partial chromosome 3 deletion in UM with metastasis-free survival
Intratumoral delivery of tavokinogene telseplasmid in metastatic melanoma
Please login below to download this issue (PDF)